Medicare could save millions of dollars every year by changing the way they package Alzheimer's medication.

A recent study suggests that a drug approved for the treatment of seizures may also help treat Alzheimer's in people who do ...

Researchers are investigating whether diabetes and eye disease drugs could also be used to treat or even prevent dementia.

Medicare could be throwing away as much as $336 million worth of a costly Alzheimer's drug each year because the size of ...

A simple tweak in available vial sizes of the breakthrough Alzheimer's drug Leqembi could save Medicare hundreds of millions ...

Sage Therapeutics said on Tuesday it would stop developing its experimental drug, dalzanemdor, for Alzheimer's disease after ...

Current vial sizes may result in 5.8% of the Alzheimer's disease drug being thrown away, representing $1,619 in wasted ...

A groundbreaking study has unveiled a potential game-changer in the fight against Alzheimer's disease. Scientists have ...

Bristol-Myers’ newly approved schizophrenia treatment might be coming full circle.

Annovis has limited cash reserves and faces challenges in financing further trials, making the future of Buntanetap uncertain ...

Australia's Therapeutic Goods Administration (TGA) has said it won't approve Eisai and Biogen's Alzheimer's disease therapy ...

Medicare could save up to 74% of the money lost from discarded Alzheimer's drug lecanemab by the simple introduction of a new ...